Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLinical Utility of the omnigrAf® biomarkeR Panel In The Care of kidneY Transplant Recipients

NCT05482100 is registered in ClinicalTrials.gov with Transplant Genomics, Inc. as lead sponsor.

NCT NCT05482100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05482100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLinical Utility of the omnigrAf® biomarkeR Panel In The Care of kidneY Transplant Recipients
Lead sponsor
Transplant Genomics, Inc.
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2022
Completion date
June 1, 2026
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant rejection